Timing of postpartum enoxaparin administration and severe postpartum hemorrhage

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 1, 2008, Pages 55-59

  Freedman, Rachel A ^a   Bauer, Kenneth A ^a   Neuberg, Donna S ^b   Zwicker, Jeffrey I ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Enoxaparin; Low molecular weight heparin; Postpartum hemorrhage

Indexed keywords

ENOXAPARIN;

ADULT; ARTICLE; CESAREAN SECTION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VAGINAL DELIVERY;

ADULT; ANTICOAGULANTS; CASE-CONTROL STUDIES; CESAREAN SECTION; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 37849018167     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3282f185dd     Document Type: Article

References (19)

1. Dulitzki M, Pauzner R, Langevitz P, Pras M, Many A, Schiff E. Lowmolecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies. Obstet Gynecol 1996; 87:380-383.
2. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106:401-407.
3. Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997; 176:1062-1068.
4. Burrows RF, Gan ET, Gallus AS, Wallace EM, Burrows EA. A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study. Br J Obstet Gynaecol 2001; 108:835-839.
5. Pettila V, Kaaja R, Leinonen P, Ekblad U, Kataja M, Ikkala E. Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy. Thromb Res 1999; 96:275-282.
6. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Committee on Obstetric Practice. ACOG Committee opinion. Safety of Lovenox in pregnancy. Number 276, October 2002. Committee on Obstetric Practice. Int J Gynaecol Obstet 2002; 79:299-300.
7. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:627S-644S.
8. Deruelle P, Denervaud M, Hachulla E, Ducloy-Bouthors AS, Valat AS, Puech F, et al. Use of low-molecular-weight heparin from the first trimester of pregnancy: A retrospective study of 111 consecutive pregnancies. Eur J Obstet Gynecol Reprod Biol 2006; 127:73-78.
9. Magann EF, Evans S, Chauhan SP, Lanneau G, Fisk AD, Morrison JC. The length of the third stage of labor and the risk of postpartum hemorrhage. Obstet Gynecol 2005; 105:290-293.
10. Magann EF, Evans S, Hutchinson M, Collins R, Lanneau G, Morrison JC. Postpartum hemorrhage after cesarean delivery: an analysis of risk factors. South Med J 2005; 98:681-685.
11. Combs CA, Laros RK Jr. Prolonged third stage of labor: morbidity and risk factors. Obstet Gynecol 1991; 77:863-867.
12. Combs CA, Murphy EL, Laros RK Jr. Factors associated with hemorrhage in cesarean deliveries. Obstet Gynecol 1991; 77:77-82.
13. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001; 322:1089-1093; discussion 1093-1094.
14. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or =500 ml) and severe (> or =1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2004; 115:166-172.
15. Sheiner E, Sarid L, Levy A, Seidman DS, Hallak M. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med 2005; 18:149-154.
16. Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991; 77:69-76.
17. Jacobsen AF, Qvigstad E, Sandset PM. Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy. Br J Obstet Gynaecol 2003; 110:139-144.
18. Lepercq J, Conard J, Borel-Derlon A, et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. Br J Obstet Gynaecol 2001; 108:1134-1140.
19. Maslovitz S, Many A, Landsberg JA, Varon D, Lessing JB, Kupferminc MJ. The safety of low molecular weight heparin therapy during labor. J Matern Fetal Neonatal Med 2005; 17:39-43.